View all research projects
Research project

Bioengineering to combat the tuberculosis pandemic

Project overview

We will combine engineering and biological approaches to investigate the host-pathogen interaction and identify new therapeutic targets.

Staff

Lead researcher

Professor Paul Elkington

Director of Inst. for Medical Innovation

Research interests

  • tuberculosis
  • immunopathology
  • diagnosis
Connect with Paul

Email: [email protected]

Other researchers

Professor Xunli Zhang PhD, DIC, FRSC, CChem, CEng

Head of Department-Chemical Engineerg

Research interests

  • Microfluidics and Lab-on-a-Chip Technologies
  • Biomedical and Chemical Engineering
  • Nanomaterials
Connect with Xunli

Email: [email protected]

Research outputs

Advanced cellular systems to study tuberculosis treatment
Magdalena K. Bielecka & Paul Elkington, 2018, Current Opinion in Pharmacology, 42, 16-21
DOI: 10.1016/j.coph.2018.06.005
Type: article
Cytokine diagnosis of pleural TB
Marc Tebruegge & Paul Elkington, 2018, Thorax, 73(3), 206-207
DOI: 10.1136/thoraxjnl-2017-210918
Type: letterEditorial
Gene expression signatures in tuberculosis have greater overlap with autoimmune than infectious diseases
Kalum Clayton, Marta Polak, Christopher H. Woelk & Paul Elkington, 2017, American Journal of Respiratory and Critical Care Medicine, 196(5)
DOI: 10.1164/rccm.201706-1248LE
Type: letterEditorial